Showing results (1371-1380 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|May 18, 2021
Assessment of interferon-γ in pleural fluid as a prognostic factor of survival in malignant pleural mesotheliomaBeatrice Dozin, Grazia Carbotti, Silvio Roncella, et al.Cancer Immunology, Immunotherapy : CII|May 19, 2021
CD74+ macrophages are associated with favorable prognosis and immune contexture in hepatocellular carcinomaNan Xiao, Kangshuai Li, Xiaodong Zhu, et al.Cancer Immunology, Immunotherapy : CII|April 30, 2021
Immune infiltrate diversity confers a good prognosis in follicular lymphomaAnna-Maria Tsakiroglou, Susan Astley, Manàs Dave, et al.Cancer Immunology, Immunotherapy : CII|May 12, 2021
Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinomaTao Fan, Yu Liu, Hengchang Liu, et al.Cancer Immunology, Immunotherapy : CII|June 25, 2020
Prognostic impacts of tumoral expression and serum levels of PD-L1 and CTLA-4 in colorectal cancer patientsYusuke Omura, Yuji Toiyama, Yoshinaga Okugawa, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell inductionS Yokota, T Shirasaka, H Nishikawa, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
In vivo generation of lymphokine activated killer cell activity by ABPP and interleukin-2 and their antitumor effects against immunogenic and nonimmunogenic tumors in murine tumor modelsA M Eggermont, P H Sugarbaker, R L Marquet, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
The immunological mouse mutants nude (nu) and rhino (hrrh) generate cytotoxic effector cells following adoptive immunotherapy but fail to reject a transplanted tumorR Evans, T M Duffy, L D ShultzCancer Immunology, Immunotherapy : CII|April 28, 2021
IL-7 coupled with IL-12 increases intratumoral T cell clonality, leading to complete regression of non-immunogenic tumorsMamoru Tasaki, Midori Yamashita, Yukinori Arai, et al.Cancer Immunology, Immunotherapy : CII|May 24, 2020
Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumorValentine Suteau, Alexandre Collin, Philippe Menei, et al.Pageof 651